Top 10 Companies in Biopharmaceutical Processing Equipment And Consumables Market

The Biopharmaceutical Processing Equipment and Consumables Market will grow at a CAGR of 10.3% during the forecast period to reach $70.84 billion by 2029. Biopharmaceutical processing involves the discovery, development, and processing of complex medicines using living cells and organisms. Biopharmaceuticals include vaccines, whole blood and blood components, gene therapies, recombinant therapeutic proteins, gene therapies, allergenics, recombinant therapeutic protein, and somatic cells.

Biopharmaceutical processing equipment includes filtration systems, chromatography equipment and consumables, bioreactors, cell culture systems, mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, biosafety cabinets, and other equipment such as membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors for commercial and research-based bioproduction.

The growth of this market is mainly attributed to the global initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical plants, and the growing adoption of single-use bioprocessing equipment and consumables. Moreover, emerging economies, shift towards bioprocessing 4.0, and rising adoption of personalized medicines offer significant opportunities for market growth.

Here are the top 10 companies operating in the Biopharmaceutical Processing Equipment and Consumables Market

Danaher Corporation (U.S.)

Founded in 1984 and headquartered in Washington D.C., U.S, Danaher Corporation is a science and technology company that focuses on providing services and products for life sciences, diagnostics, and environmental sectors.

The company operates through three reportable segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company operates in the biopharmaceutical processing equipment and consumables market through its Life Sciences business segment. The company offers consumables and instruments for the testing and manufacturing of new drugs and vaccines.

The company operates in more than 60 countries globally. The company has 239 facilities that carry out administrative, sales, research and development, manufacturing, and distribution activities, out of which 98 facilities are in the U.S. and 141 other facilities are in Europe, South America, Asia, Rest of North America, and Australia. The manufacturing facilities for the Life Sciences business segment are in North America, Europe, Asia, and New Zealand. The major subsidiaries of the company operating in the biopharmaceutical processing equipment and consumables market are Phenomenex, Inc. (U.S.), Cytiva (U.S.), Beckman Coulter, Inc. (U.S.), and Pall Corporation (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Founded in 1956 and is headquartered in Massachusetts, U.S., Thermo Fisher Scientific Inc. is a biotechnology company primarily engaged in accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics, and increasing laboratory productivity.

The company operates through four reportable business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions business segment is further divided into four primary businesses: Biosciences, Genetic Sciences, Clinical Next-Generation Sequencing, and BioProduction.

The company operates in the biopharmaceutical processing equipment and consumables market through its BioProduction segment. The company offers chromatography and protein purification systems, cell culture products, media and consumables, cell and cell lines, and bio-reactors through its BioProduction segment.

The company’s Life Sciences Solutions business segment has a direct presence in the U.S. through its operational offices, laboratories, and production sites, offering services across Australia, Canada, India, China, Denmark, Finland, France, Germany, Japan, the Netherlands, Singapore, Sweden, the U.K., and the U.S. among others. Some of the subsidiaries of the company operating in the biopharmaceutical processing equipment and consumables market are Advanced Scientifics, Inc. (ASI) (U.S.), Fisher Clinical Services (Suzhou) Co., Ltd. (China), and Thermo Fisher Germany B.V. (Netherlands) among others.

Sartorius AG (Germany)

Founded in 1870 and headquartered at Göttingen, GermanySartorius AG is a laboratory equipment supplier and pharmaceutical company that is involved in providing products and services for laboratory and bioprocess solutions.

The company operates in two reportable segments: Bioprocess Solutions Division and Lab Products & Services Division. The company operates in the biopharmaceutical processing equipment and consumables market through its Bioprocess Solutions Division. The company offers fermenters, bioreactors, filtration and purification products, and chromatography systems, and columns & consumables among others.

The company has a presence in more than 20 countries worldwide. The company has Bioprocess Solutions facilities in Germany, France, Puerto Rico, India, the U.K., Tunisia, Switzerland, the U.S., China, and Slovenia among others. The major subsidiaries of the company operating in biopharmaceutical processing equipment and consumables are Sartorius Stedim Biotech S.A. (France), Sartorius Stedim Belgium N.V. (Belgium), and WaterSep BioSeparations LLC, (U.S.) among others.

3M Company (U.S.)

Founded in 1929 and is headquartered in Minnesota, U.S., 3M Company is involved in the manufacturing of diverse products like adhesives, abrasives, laminates, dental products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films among others.

The company has four reportable business segments: Safety and Industrial, Transportation and Electronics, Health Care, and Consumer. The Health Care business segment is further divided into seven sub segments: Drug Delivery (divestiture of Drug Delivery segment occurred in May 2020), Food Safety, Health Information Systems, Medical Solutions, Oral Care, Separation and Purification Sciences, and Other Health Care.

The company operates in the biopharmaceutical processing and equipment and consumables market through its Healthcare business segment and Separation and Purification Sciences sub segment. It offers filtration and purification systems for biopharmaceuticals manufacturing. The purification filters offered by the company include various filters like membrane filters, activated carbon filters, and chromatography filters among others.

The company operates in more than 70 countries, making its presence in North America, Asia-Pacific, Europe, and Middle East & Africa. The company has a direct presence in 35 countries through its 97 manufacturing and converting facilities. The company has 64 manufacturing facilities in the U.S. and has a strong network of distributors globally. Some of the company’s subsidiaries operating in the biopharmaceutical processing and equipment and consumables market are 3M Purification SAS (France) and 3M Purification, Inc. (U.S.) among others.

Bio-Rad Laboratories, Inc. (U.S.)

Founded in 1952 and headquartered in California, U.S., Bio-Rad Laboratories, Inc. is involved in the manufacturing and distribution of life sciences and clinical diagnostics products. The company operates its business in two reportable segments: Life Sciences and Clinical Diagnostics.

The company operates in the biopharmaceutical processing equipment and consumables market through its Life Sciences business segment. The company offers reagents, apparatus, and laboratory instruments through this business segment. The principal end users of the company’s products are industrial research organizations, medical schools and universities, government agencies, pharmaceutical manufacturers, and biotechnology researchers.

The company operates through 140 locations in 36 countries globally. The company has three R&D and manufacturing facilities for life sciences operations in the U.S., the U.K., and Singapore.

The company operates through its sales & administration and distribution activities in France, Switzerland, Germany, Korea, India, Thailand, Italy, the U.A.E, Japan, Australia, Belgium, Brazil, China, Denmark, Hungary, and Greece among others. Some of the major subsidiaries of the company are Bio-Rad Laboratories (Singapore) Pte Ltd (Singapore), Bio-Rad Europe GmbH (Switzerland), and Bio-Rad Laboratories AG (Switzerland) among others.

Meticulous Research in its latest publication on Biopharmaceutical Processing Equipment and Consumables Market has predicted the growth of 10.3% during the forecast year 2022-2029.

Agilent Technologies, Inc. (U.S.)

Founded in 1999 and headquartered in California, U.S., Agilent Technologies, Inc. Agilent Technologies, Inc. is involved in providing analytical instruments, consumables, services, and software to laboratories.

The company operates in three reportable segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The company operates in the biopharmaceutical processing equipment and consumables market through its Life Sciences and Applied Markets business segment. The company offers chromatography equipment and consumables and components to identify, quantify and analyze the physical and biological properties of substances and products.

The company operates in major regions of the Americas, Europe, Africa, and Asia-Pacific. The company has manufacturing facilities in the U.S., Germany, Malaysia, and Singapore for its Life Sciences and Applied Markets business segment.

The company has an indirect presence through its distributors in Argentina, Belarus, Belgium, Mexico, Finland, Italy, Ireland, Columbia, Poland, Portugal, Russia, and Norway among others. The major subsidiaries of the company are Agilent Technologies Luxco S.à.r.l. (Luxemburg), Agilent Technologies Singapore (Global) Pte Ltd. (Singapore), and Agilent Technologies Singapore (International) Pte. Ltd. (Singapore) among others.

Merck KGaA (Germany)

Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a science and technology company that provides products and services for therapeutic areas such as allergies, fertility, oncology, and neurodegenerative diseases, developing drugs, diagnostic substances, and medical devices.

The company also provides solutions that facilitate biotechnology and pharmaceutical research. In addition, the company provides specialty chemicals for various applications, including materials for integrated circuits, liquid crystals for electronic displays, effect pigments for coatings and color cosmetics, functional materials for energy solutions, as well as effect pigments for coatings and color cosmetics.

The company operates in three reportable business segments: Healthcare, Life Sciences, and Performance Materials. The Life Sciences business segment is further divided into three categories: Research Solutions, Process Solutions, and Applied Solutions. The company operates in the biopharmaceutical processing equipment and consumables market through its Life Sciences business segment (Process Solutions). The company offers various solutions, including filtration, chromatography, process development, and manufacturing among others, for the development and manufacturing of biologics-based drugs.

The company operates directly through its offices, subsidiaries, and facilities in countries namely, Cyprus, France, Egypt, Germany, Morocco, the Netherlands, Switzerland, Tunisia, Uruguay, Greece, China, Indonesia, South Korea, Bahrain, Lebanon, Jordan, the U.S., Iraq, Paraguay, Bolivia, Austria, Croatia, Brazil, Sweden, Romania, Macedonia, Canada, New Zealand, Singapore, Spain, Denmark, Finland, Italy, Portugal, Ireland, the U.K., Japan, Norway, Peru, and Colombia among others.

The company has manufacturing facilities in the U.S., Germany, and Switzerland among others. Some of the major subsidiaries of the company are Merck Millipore Ltd. (Ireland), Millipore S.A.S. (France), Merck Serono S.A.S. (France), Merck Life Science OY (Finland), and Merck Life Science A/S (Denmark) among others.

Eppendorf AG (Germany)

Founded in 1945 and headquartered in Hamburg, Germany Eppendorf AG is a biotechnology company that is involved in the development, manufacturing, and commercialization of products and services for laboratories.

The company operates in four business segments: Liquid Handling, Consumables, Separation and Instrumentation, and Lab Solutions. The company operates in the biopharmaceutical processing equipment and consumables market through its Separation and Instrumentation and Lab Solutions business segments. The company offers centrifuges, shakers, mixers, and bioreactors & fermenters, along with other consumables in the biopharmaceutical processing equipment and consumables market.

The company operates in more than 30 countries globally. The company has a direct presence through its offices, sale subsidiaries, and facilities in countries namely, Ireland, Belgium, the U.K., Poland, France, Austria, Denmark, Czechia, Russia, Spain, Italy, the U.A.E., India, Thailand, China, South Korea, Japan, Malaysia, the U.S., Brazil, and Australia among others.

SOLARIS BIOTECHNOLOGY SRL (Italy)

Founded in 2002 and headquarters in Mantovano, Italy, Solaris Biotechnology Srl manufacturers equipment for biotech, pharmaceutical, food & beverage, and dairy industry. The company offers bioreactors, fermenters, cGMP solutions, and filtration systems. The company also offers Clean-In-Place systems, consumables, and other related instruments.

The company has a direct presence in the U.S. through its subsidiary and in Malaysia through its sales & service facility. The company has more than 30 distributors operating all around the world. The only known subsidiary of the company operating in the biopharmaceutical processing equipment and consumables market is Solaris Biotech USA (U.S.).

Repligen Corporation (U.S.)

Founded in 1981 and headquarters in Massachusetts, U.S., Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems to increase efficiency and flexibility in the manufacturing of biological drugs. The company provides filtration systems for biologic drugs manufacturing, chromatography systems for downstream processes, and protein A ligands for downstream purification for monoclonal antibody-based drugs.

The company has a direct presence through its 19 manufacturing facilities, subsidiaries, and offices in the U.S., Lebanon, Netherlands, Germany, Sweden, Ireland, Estonia, France, China, India, Japan, South Korea, and Singapore. The company operates indirectly through its distributors in Asia, Mexico, Russia, Armenia, Azerbaijan, Belarus, Georgia, and Kazakhstan among others. T

he major subsidiaries of the company operating in the biopharmaceutical processing equipment and consumables market are Repligen (Shanghai) Biotechnology Co. Ltd. (China), Repligen India Pvt. Ltd. (India), Repligen Japan LLC (Japan), Repligen Korea Co., Ltd. (South Korea), and Repligen Singapore Pte. Ltd. (Singapore).

Authoritative Research on the Biopharmaceutical Processing Equipment and Consumables Market – Global Opportunity Analysis and Industry Forecast (2022-2029)

Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:

• Recent financial performance
• Key products
• Significant company strategies
• Partnerships and acquisitions

The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.